Skip to content
Back to event

KalshiKalshi· Science and Technology

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027?

Chance

36%

Buy Yes

39¢

pays $1 if it happens

Buy No

67¢

pays $1 if it doesn’t

Prices from Kalshi, updated 5 minutes ago. Ends Jan 1, 4:59 AM UTC.

Price over the last 2 weeks
Cost of a Yes share

Latest trades

  • 5 hours agoBought no at 67¢$2
  • 16 hours agoBought no at 66¢$1
  • 23 hours agoBought no at 63¢$6
  • 23 hours agoBought no at 64¢$3
How this market is decidedShow

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.